Flavell K J, Murray P G
Department of Pathology, Medical School, University of Birmingham, UK.
Mol Pathol. 2000 Oct;53(5):262-9. doi: 10.1136/mp.53.5.262.
Hodgkin's disease is an unusual cancer because the malignant cells constitute only a minority of the total tumour mass and, as a consequence, the study of these cells has been a major challenge. Recently, the application of newer technologies, such as single cell polymerase chain reaction (PCR) and gene expression array analysis, to the study of Hodgkin's disease have yielded new insights into the pathogenesis of this tumour. In addition, the recognition that a proportion of Hodgkin's disease tumours harbour the Epstein-Barr virus (EBV) and that its genome is monoclonal in these tumours suggests that the virus contributes to the development of Hodgkin's disease in some cases. This review summarises current knowledge of the pathogenesis of Hodgkin's disease with particular emphasis on the association with EBV.
霍奇金淋巴瘤是一种特殊的癌症,因为恶性细胞仅占肿瘤总体积的一小部分,因此,对这些细胞的研究一直是一项重大挑战。最近,诸如单细胞聚合酶链反应(PCR)和基因表达阵列分析等新技术应用于霍奇金淋巴瘤的研究,为该肿瘤的发病机制带来了新的见解。此外,认识到一部分霍奇金淋巴瘤肿瘤含有爱泼斯坦-巴尔病毒(EBV),并且在这些肿瘤中其基因组是单克隆的,这表明该病毒在某些情况下促成了霍奇金淋巴瘤的发生。本综述总结了霍奇金淋巴瘤发病机制的当前知识,特别强调了与EBV的关联。